Product Images Duloxetine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 13 images provide visual information about the product associated with Duloxetine NDC 0615-8496 by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Structure - duloxetine dr caps 8494 8495 8496 1

Structure - duloxetine dr caps 8494 8495 8496 1

Figure 10 - duloxetine dr caps 8494 8495 8496 10

Figure 10 - duloxetine dr caps 8494 8495 8496 10

This text appears to be a table or chart showing the percentage of patients improved in a study comparing a placebo with duloxetine at 60/120 mg once daily. The table also includes a scale indicating percent improvement in pain from baseline.*

PRINCIPAL DISPLAY PANEL - 20 MG - duloxetine dr caps 8494 8495 8496 11

PRINCIPAL DISPLAY PANEL - 20 MG - duloxetine dr caps 8494 8495 8496 11

PRINCIPAL DISPLAY PANEL - 30 MG - duloxetine dr caps 8494 8495 8496 12

PRINCIPAL DISPLAY PANEL - 30 MG - duloxetine dr caps 8494 8495 8496 12

PRINCIPAL DISPLAY PANEL - 60 MG - duloxetine dr caps 8494 8495 8496 13

PRINCIPAL DISPLAY PANEL - 60 MG - duloxetine dr caps 8494 8495 8496 13

Figure 1 - duloxetine dr caps 8494 8495 8496 2

Figure 1 - duloxetine dr caps 8494 8495 8496 2

This text provides data on the proportion of patients with relapse in a study comparing the treatment of Placebo and Duloxetine. However, the information is incomplete and not clear enough to draw any specific conclusions.*

Figure 2 - duloxetine dr caps 8494 8495 8496 3

Figure 2 - duloxetine dr caps 8494 8495 8496 3

This text provides information about the proportion of patients experiencing relapse in a study comparing a placebo treatment to duloxetine. The data includes specific percentages corresponding to different time periods from randomization to relapse. Additionally, it mentions the use of the Kaplan-Meier estimator method for analysis.*

Figure 1 - duloxetine dr caps 8494 8495 8496 4

Figure 1 - duloxetine dr caps 8494 8495 8496 4

Figure 2 - duloxetine dr caps 8494 8495 8496 5

Figure 2 - duloxetine dr caps 8494 8495 8496 5

fig 5 - duloxetine dr caps 8494 8495 8496 6

fig 5 - duloxetine dr caps 8494 8495 8496 6

fig 6 - duloxetine dr caps 8494 8495 8496 7

fig 6 - duloxetine dr caps 8494 8495 8496 7

Figure 8 - duloxetine dr caps 8494 8495 8496 8

Figure 8 - duloxetine dr caps 8494 8495 8496 8

Not available*

Figure 9 - duloxetine dr caps 8494 8495 8496 9

Figure 9 - duloxetine dr caps 8494 8495 8496 9

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.